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Process intensification through integration of upstream perfusion cell culture with downstream 
continuous chromatography in monoclonal antibody production 
 
Andreas Castan, Thomas Falkman, Eric Fäldt, Teres Persson, Lisa Blomqvist and Annika Forss 
 
GE Healthcare Bio-Sciences AB, Björkgatan 30, 751 84 Uppsala, Sweden  
 
Process intensification is gaining interest as a strategy to reduce production costs, while improving product 
quality and throughput in the manufacturing of biopharmaceuticals. For a competitive production process, 
continuous or semi-continuous upstream and downstream processing can be employed. Compared with a 
process performed in batch runs, continuous processing allows for increased capacity utilization and 
eliminates or minimized the need for intermediate hold-up steps. Here, we describe the integration of a high-
performing upstream cell culture process with downstream purification utilizing new emerging technologies 
such as periodic counter-current (PCC) chromatography and straight-through processing (STP). 
 
A high-cell density perfusion process based on commercially available ActiCHO™ cell culture media was 
developed for a MAb-producing Chinese hamster ovary (CHO) cell line. Medium prototypes were evaluated 
in small scale using the single-use ReadyToProcess WAVE™ 25 bioreactor system. Medium optimization 
resulted in a final process with a cell-specific perfusion rate (CSPR) of less than 50 pL/cell/d. Process 
performance was verified at laboratory scale using single-use stirred-tank bioreactor systems. Productivity 
and product quality of the developed perfusion process were compared with a standard fed-batch process. 
 
MAb capture on MabSelect SuRe™ LX protein A chromatography medium (resin) was performed in a three-
column PCC (3C PCC) setup. The capture step was followed by two polishing steps using Capto™ S ImpAct 
ion exchange and Capto adhere multimodal ion exchange media in serially connected columns in a STP 
setup. MAb purity and yield of the developed continuous processes were compared with traditional setups 
performed in batch runs. 
 
In this case study, we demonstrate the feasibility of integrated upstream and downstream MAb processing 
performed in a continuous manner. The developed process shows a performance equivalent to traditional 
processing performed in batch runs.  
 
 
 
